TScan Therapeutics, Inc. Common Stock Share Price
NASDAQ: TCRXHealthcare
Live TScan Therapeutics, Inc. Common Stock Share Price Chart
O H L
TScan Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$0.33Low
$0.36High
Markets Today
| Previous Close | $0.33 |
|---|---|
| Open | $0.33 |
| Volume | 1,096,263 |
| Day's Range | $0.33 - $0.36 |
| 52W Range | $0.29 - $2.57 |
| Market Cap | $22.43 M |
Historical Performance
| 1M Returns | -59.56 |
|---|---|
| 3M Returns | -63.75 |
| 6M Returns | -68.83 |
| 1Y Returns | -80.61 |
| 5Y Returns | -94.66 |
| 10Y Returns | -98.70 |
TScan Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $22.43 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $10.32 M |
| ROE TTM | -0.71 |
| EPS TTM | $-0.91 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.33 |
| EBITDA | $-132.95 M |
| Profit Margin | -1256.81 |
| Market Cap | $22.43 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $10.32 M |
| ROE TTM | -0.71 |
| EPS TTM | $-0.91 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.33 |
| EBITDA | $-132.95 M |
| Profit Margin | -1256.81 |
TScan Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $2.17 M | $3.08 M | $2.51 M | $2.57 M | $982.00 K | $1.05 M |
| Gross Profit + | $2.17 M | $3.08 M | $2.51 M | $2.57 M | $982.00 K | $1.05 M |
| Operating Income | -$36.25 M | -$38.65 M | -$37.05 M | -$23.86 M | -$29.14 M | -$30.49 M |
| EBITDA | -$35.57 M | -$37.95 M | -$36.28 M | -$23.14 M | -$28.45 M | -$29.79 M |
| Interest Expense | -$679.00 K | -$689.00 K | -$699.00 K | -$702.00 K | -$689.00 K | -$699.00 K |
| Depreciation | $678.00 K | $698.00 K | $767.00 K | $723.00 K | $693.00 K | $699.00 K |
| Income Before Tax | -$34.13 M | -$36.95 M | -$35.71 M | -$22.98 M | -$28.67 M | -$30.36 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$34.13 M | -$36.95 M | -$35.71 M | -$22.98 M | -$28.67 M | -$30.36 M |
| Net Profit Margin | -1571.95% | -1201.3% | -1422.14% | -895.09% | -2919.14% | -2888.58% |
TScan Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $6.00 K | $6.00 K | $6.00 K | $6.00 K | $7.00 K | $8.00 K |
| Reserve & Surplus | -$409.23 M | -$446.18 M | -$481.88 M | -$504.86 M | -$533.53 M | -$563.89 M |
| Non-Current Liabilities | $92.69 M | $90.53 M | $89.00 M | $86.97 M | $85.10 M | $71.47 M |
| Current Liabilities | $29.82 M | $31.32 M | $29.21 M | $18.70 M | $19.97 M | $30.96 M |
| Total Liabilities | $122.51 M | $121.85 M | $118.20 M | $105.67 M | $105.07 M | $102.43 M |
| Fixed Assets | $8.35 M | $9.52 M | $9.30 M | $8.71 M | $8.12 M | $7.74 M |
| Current Assets | $254.84 M | $221.13 M | $188.16 M | $157.21 M | $132.77 M | $104.40 M |
| Total Assets | $332.71 M | $298.56 M | $262.23 M | $228.79 M | $201.99 M | $171.45 M |
TScan Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$34.13 M | -$36.95 M | -$35.71 M | -$22.98 M | -$28.67 M | -$30.36 M |
| Operating Cash Flow | -$37.59 M | -$33.27 M | -$32.86 M | -$31.60 M | -$24.28 M | -$27.54 M |
| Investing Cash Flow | $13.53 M | $48.44 M | $32.58 M | $14.83 M | -$70.00 K | -$465.00 K |
| Financing Cash Flow | -$525.00 K | $116.00 K | $400.00 K | -$327.00 K | $0 | $99.00 K |
| Change in Cash | -$24.58 M | $15.29 M | $112.00 K | -$17.10 M | -$24.35 M | -$27.90 M |
TScan Therapeutics, Inc. Common Stock Return Calculator
The TScan Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$529
Invested Amount$10,000
Est. Returns$-9,471
About TScan Therapeutics, Inc. Common Stock
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
Popular Stocks
FAQs
What is the share price of TScan Therapeutics, Inc. Common Stock today?
TScan Therapeutics, Inc. Common Stock (TCRX) share price as of September 18, 2026 is $0.33. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of TScan Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the TScan Therapeutics, Inc. Common Stock (TCRX) Share by opening an international trading account with Angel One.
How can I purchase TScan Therapeutics, Inc. Common Stock shares in India?
Purchasing TScan Therapeutics, Inc. Common Stock (TCRX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying TScan Therapeutics, Inc. Common Stock (TCRX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of TScan Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of TScan Therapeutics, Inc. Common Stock (TCRX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of TScan Therapeutics, Inc. Common Stock?
The market capitalization of TScan Therapeutics, Inc. Common Stock on September 18, 2026, is $22.43 M.
In which sector TScan Therapeutics, Inc. Common Stock belongs?
TScan Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in TScan Therapeutics, Inc. Common Stock stocks?
In order to invest in TScan Therapeutics, Inc. Common Stock (TCRX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
